NAD Therapy

Nicotinamide Adenine Dinucleotide or NAD is an active form of vitamin B3. NAD is essential in making ATP (Adenosine Triphosphate) which is our cells source of energy. NAD plays apart in structuring, repair, and remodeling in every cell. 

• Brain fog
• Fatigue 
• Lacks motivation 
• Loss of enthusiasm 

The use of NAD continues to change and expand. Especially, in neurodegenerative disorders and most chronic conditions. This is due in part to the nature of chronic conditions which may be a result of being in a low energy state. For this reason most metabolic disorders and diseases come to fruition sooner, when our lifestyle, diet and environment are not optimized.

• Increase energy in heart muscle cells.
• Increased energy in brain cells.
• DNA protection and repair.
• Protects the brain from aging.
• Lowers cholesterol. 
• Strengthens the immune system.
• Improves mood, concentration and memory by making more dopamine, serotonin, and noradrenaline. 
• Increases blood flow by stimulating nitric oxide production.
• Improves insulin resistance and blood sugar levels.
• Decreases brain inflammation. 

• Chronic Fatigue
• Muscle pain and weakness
• Joint Pain and Stiffness
• Headaches
• Depression 
• Anxiety 
• Alcohol and Drug addiction
• Diabetes
• Sleep Disturbance 
• Memory loss 
• Attention Deficit Disorder
• Parkinson's Disease
• Alzheimer's

• 100mg                  $283.00
• 200mg                 $321.00
• 300mg                 $360.00
• 400mg                 $398.00
• 500mg                 $437.00
• 750mg                 $533.00
• 1000mg               $629.00

*All NAD dosages and prices include a multivitamin and mineral IV bag:

• Vitamin C, Calcium, Magnesium, Potassium, Zinc, B1, B1, B5, B6, B9, B12, Carnitine, Taurine 
• IV bag will be infused prior to NAD IV

*Prices subject to change based on supply 

*A $50 discount is applied to each IV session, for patients requiring more than 1 IV session. 

Cantó C, Menzies K, Auwerx J. NAD+ metabolism and the control of energy homeostasis - a balancing act between mitochondria and the nucleus. Cell metabolism. 2015;22(1):31-53. doi:10.1016/j.cmet.2015.05.023. 

Samuel A. J. Trammell, Mark S. Schmidt, Benjamin J. Weidemann, Philip Redpath, Frank Jaksch, Ryan W. Dellinger, Zhonggang Li, E. Dale Abel, Marie E. Migaud& Charles Brenner. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications volume 7, Article number: 12948 (2016)

Santaella ML, Font I, Disdier OM. Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome. P R Health Sci J. 2004 Jun;23(2):89-93.

Alegre J, Rosés JM, Javierre C, Ruiz-Baqués A, Segundo MJ, de Sevilla TF. [Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome]. [Article in Spanish] Rev Clin Esp. 2010 Jun;210(6):284-8. doi: 10.1016/j.rce.2009.09.015. Epub 2010 May 5.

Castro-Marrero J, et.al. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial. Clin Nutr. 2016 Aug;35(4):826-34. doi: 10.1016/j.clnu.2015.07.010. Epub 2015 Jul 17.

Birkmayer JG, et al. Nicotinamide adenine dinucleotide (NADH)--a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application. Acta Neurol ScandSuppl. 1993. PMID 8101414 

 Birkmayer JG, et al. On the safety of reduced nicotinamide adenine dinucleotide (NADH). J Environ Pathol Toxicol Oncol. 2004. PMID 15312041 

 Kuhn W, et al. Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis. J Neural Transm(Vienna). 1996. PMID 9013405